These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1661086)

  • 1. Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes.
    Millar BC; Weis T; Piper HM; Weber M; Borchard U; McDermott BJ; Balasubramaniam A
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1727-33. PubMed ID: 1661086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPY-(18-36) and pertussis toxin distinguish between the negative and positive contractile effects of neuropeptide Y (NPY) in ventricular cardiomyocytes.
    Millar BC; McDermott BJ; Piper HM; Balasubramaniam A; Weis T
    Adv Exp Med Biol; 1992; 311():325-6. PubMed ID: 1529762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
    Heredia MP; Fernández-Velasco M; Benito G; Delgado C
    Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers.
    Noll T; Hempel A; Piper HM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1878-83. PubMed ID: 8945904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neuropeptide Y on cell length and membrane currents in isolated guinea pig ventricular myocytes.
    Bryant SM; Ryder KO; Hart G
    Circ Res; 1991 Oct; 69(4):1106-13. PubMed ID: 1934339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative contractile effects of somatostatin-14 on rat ventricular cardiomyocytes.
    Murray F; Bell D; Kelso EJ; Millar BC; McDermott BJ
    J Cardiovasc Pharmacol; 2001 Mar; 37(3):324-32. PubMed ID: 11243423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Millar BC; Piper HM; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):426-9. PubMed ID: 2854210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.
    Hackenthal E; Aktories K; Jakobs KH; Lang RE
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F543-50. PubMed ID: 3548437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis toxin unmasks stimulatory myocardial A2-adenosine receptors on ventricular cardiomyocytes.
    Stein B; Mende U; Neumann J; Schmitz W; Scholz H
    J Mol Cell Cardiol; 1993 Jun; 25(6):655-9. PubMed ID: 8411191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells.
    Besecke LM; Wolfe AM; Pierce ME; Takahashi JS; Levine JE
    Endocrinology; 1994 Oct; 135(4):1621-7. PubMed ID: 7925125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y reduces calcium current and inhibits acetylcholine release in nodose neurons via a pertussis toxin-sensitive mechanism.
    Wiley JW; Gross RA; Lu YX; Macdonald RL
    J Neurophysiol; 1990 Jun; 63(6):1499-507. PubMed ID: 2358888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin attenuates postsynaptic actions of neuropeptide Y on the guinea-pig uterine artery.
    Morris JL
    Eur J Pharmacol; 1991 Oct; 203(2):275-81. PubMed ID: 1800121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin abolishes the effect of neuropeptide Y on rat resistance arteriole contraction.
    Andriantsitohaina R; Andre P; Stoclet JC
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1427-32. PubMed ID: 1700631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
    Zheng J; Morrisett RA; Zhu J; Hexum TD
    J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
    Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
    Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of neuropeptide Y on ion channels in ventricular myocytes].
    Zhao HC; Liu ZB; Feng QL; Cui XL; Zhang CM; Wu BW
    Sheng Li Xue Bao; 2006 Jun; 58(3):225-31. PubMed ID: 16786106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
    Connor M; Yeo A; Henderson G
    Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.